Tyvaso and Cirrhosis alcoholic - a phase IV clinical study of FDA data
Cirrhosis alcoholic is reported only by a few people who take Tyvaso.
The phase IV clinical study analyzes which people take Tyvaso and have Cirrhosis alcoholic. It is created by eHealthMe based on reports of 32,955 people who have side effects while taking Tyvaso from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
32,955 people reported to have side effects when taking Tyvaso.
Among them, 3 people (0.01%) have Cirrhosis alcoholic.
What is Tyvaso?
Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 29,812 Tyvaso users for its effectiveness, alternative drugs and more.
What is Cirrhosis alcoholic?
Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 363 drugs and 162 conditions by eHealthMe.
Number of Tyvaso and Cirrhosis alcoholic reports submitted per year:
Gender of people who have Cirrhosis alcoholic when taking Tyvaso *:
- female: 0.0 %
- male: 100 %
Age of people who have Cirrhosis alcoholic when taking Tyvaso *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 0.0 %
- 60+: 66.67 %
Common drugs people take besides Tyvaso *:
- Revatio: 3 people, 100.00%
- Veletri: 1 person, 33.33%
- Solu-Medrol: 1 person, 33.33%
- Pantoprazole: 1 person, 33.33%
- Ambrisentan: 1 person, 33.33%
Common side effects people have besides Cirrhosis alcoholic *:
- Liver Disorder (liver diseases): 2 people, 66.67%
Common conditions people have *:
- Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 2 people, 66.67%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 33.33%
- Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Tyvaso and have Cirrhosis alcoholic?Check whether Cirrhosis alcoholic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cirrhosis alcoholic and when was it recovered:
Expand to all the drugs that have ingredients of treprostinil sodium:
Alternative drugs to, pros and cons of Tyvaso:
- Tyvaso (29,812 reports)
Common Tyvaso side effects:
Browse all side effects of Tyvaso:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cirrhosis alcoholic treatments and more:
- Cirrhosis alcoholic (749 reports)
COVID vaccines that are related to Cirrhosis alcoholic:
- Cirrhosis alcoholic in Moderna COVID Vaccine
- Cirrhosis alcoholic in Pfizer BioNTech Covid Vaccine
- Cirrhosis alcoholic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (363 drugs)
All the conditions that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (162 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on treprostinil sodium (the active ingredients of Tyvaso) and Tyvaso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fludrocortisone Acetate and Namenda drug interaction - 4 seconds ago
- Methergine vs. Treximet - 7 seconds ago
- Losartan and Primary Hyperaldosteronism - 9 seconds ago
- Losartan Potassium and Primary Hyperaldosteronism - 10 seconds ago
- Menopausal Symptoms and Bedridden - 15 seconds ago
- Lescol Xl and Lopressor drug interaction - 21 seconds ago
- Quetiapine Fumarate and Femur Fracture - 29 seconds ago
- Warfarin Sodium and Routine Health Maintenance - 37 seconds ago
- Acute Coronary Syndrome and Hypertransaminasaemia - 38 seconds ago
- Provigil and Papilloedema - 43 seconds ago